Download Free Sample Report

Precision Cancer Tests Market, Global Outlook and Forecast 2023-2029

Precision Cancer Tests Market, Global Outlook and Forecast 2023-2029

  • Published on : 03 June 2023
  • Pages :66
  • Report Code:SMR-7703772

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

Precision cancer tests encompass imaging and in vitro diagnostic products and procedures that directly detect malignancies in patient samples or in the patients themselves.
This report aims to provide a comprehensive presentation of the global market for Precision Cancer Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Cancer Tests. This report contains market size and forecasts of Precision Cancer Tests in global, including the following market information:
Global Precision Cancer Tests Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Precision Cancer Tests market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Imaging Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Precision Cancer Tests include Abbott, BD, Bio-Rad, Cynvenio Biosystems, Foundation Medicine, Genomic Health, Illumina, Myriad Genetics and NanoString Technologies, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Precision Cancer Tests companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Precision Cancer Tests Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Precision Cancer Tests Market Segment Percentages, by Type, 2022 (%)
Imaging
In Vitro Diagnostic
Others
Global Precision Cancer Tests Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Precision Cancer Tests Market Segment Percentages, by Application, 2022 (%)
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics
Others
Global Precision Cancer Tests Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Precision Cancer Tests Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Precision Cancer Tests revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Precision Cancer Tests revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
BD
Bio-Rad
Cynvenio Biosystems
Foundation Medicine
Genomic Health
Illumina
Myriad Genetics
NanoString Technologies
QIAGEN
Randox Laboratories
Roche
Philips
Thermo Fisher Scientific
Outline of Major Chapters:
Chapter 1: Introduces the definition of Precision Cancer Tests, market overview.
Chapter 2: Global Precision Cancer Tests market size in revenue.
Chapter 3: Detailed analysis of Precision Cancer Tests company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Precision Cancer Tests in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.